Combined targeted therapy and immunotherapy for cancer treatment

Although targeted therapies and immunotherapies have been effective against several malignancies, the respective monotherapies are limited by low and/or short-term responses. Specific inhibitors of oncogenic signaling pathways and tumor-associated angiogenesis can activate the anti-tumor immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Cheng-Xiang, Huang, Xing, Xu, Jian, Zhang, Xiao-Zhen, Shen, Yi-Nan, Liang, Ting-Bo, Bai, Xue-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462242/
https://www.ncbi.nlm.nih.gov/pubmed/34621816
http://dx.doi.org/10.12998/wjcc.v9.i26.7643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462242/
https://www.ncbi.nlm.nih.gov/pubmed/34621816
http://dx.doi.org/10.12998/wjcc.v9.i26.7643

Ejemplares similares